Plain-English translation of NCT01408225 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — essentially a database — designed to collect information from patients diagnosed with plasma cell dyscrasias (a group of blood cancers including multiple myeloma and amyloidosis) across Ohio. By sharing your medical records, test results, and health history with researchers at Ohio State University, you'll help doctors understand these conditions better and develop new ways to improve care and outcomes for patients like you.
These blood cancers are serious and complex, and doctors need more information to figure out which treatments work best and how to prevent serious complications. By gathering data from many patients over time, researchers can identify patterns and test new approaches to reduce suffering and improve survival.
You likely qualify if…
You likely don't qualify if…
You would work with the Ohio State myeloma clinic to share your medical records, test results, and health information — information your doctors already have. Researchers may also ask you to donate blood or tissue samples if appropriate for your care. There is no specific medication being tested in this study; instead, you're helping build a long-term database that tracks how patients with these conditions do over time, which will inform future treatment research.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States
Enrollment target
~5,000 participants
Started
March 2011
Primary completion
March 2050
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
The Ohio State University Comprehensive Cancer Center
Ohio State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.